SEVERINO, paolo
 Distribuzione geografica
Continente #
NA - Nord America 1241
EU - Europa 437
AS - Asia 131
AF - Africa 16
SA - Sud America 4
OC - Oceania 1
Totale 1830
Nazione #
US - Stati Uniti d'America 1226
IT - Italia 245
IN - India 81
SE - Svezia 62
DE - Germania 42
CN - Cina 36
UA - Ucraina 21
RO - Romania 16
CA - Canada 13
TG - Togo 13
FI - Finlandia 9
GB - Regno Unito 8
ES - Italia 6
FR - Francia 6
NL - Olanda 6
BE - Belgio 5
IR - Iran 4
PL - Polonia 4
AR - Argentina 3
KR - Corea 3
MY - Malesia 3
RU - Federazione Russa 3
VN - Vietnam 3
BZ - Belize 2
ZA - Sudafrica 2
AU - Australia 1
CL - Cile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IE - Irlanda 1
SC - Seychelles 1
Totale 1830
Città #
Fairfield 223
Chandler 135
Woodbridge 98
Cambridge 84
Houston 83
Rome 79
Wilmington 79
Seattle 77
Ashburn 76
San Paolo di Civitate 59
Ann Arbor 51
Princeton 51
Lawrence 37
Dearborn 28
Millbury 25
San Diego 22
Plano 16
Boston 15
Lomé 13
Andover 10
Bremen 10
Norwalk 9
Hefei 8
Beijing 7
Centrale 7
Madrid 6
Nanjing 6
Ottawa 6
Phoenix 6
Toronto 6
Brussels 5
Jacksonville 5
Buffalo 4
Fremont 4
Redwood City 4
San Mateo 4
Amsterdam 3
Federal 3
Kunming 3
Neuenstadt 3
Rozzano 3
Belize City 2
Bologna 2
Bucharest 2
Des Moines 2
Florence 2
Formia 2
Hung Yen 2
Labico 2
Lamon 2
Latina 2
London 2
Milan 2
Nanchang 2
Pesaro 2
Portland 2
Simi Valley 2
Alghero 1
Bangalore 1
Berlin 1
Busto Arsizio 1
Chengdu 1
Ciampino 1
Columbus 1
Dallas 1
Dublin 1
Falls Church 1
Fort Worth 1
Fuzhou 1
Grafing 1
Guangzhou 1
Guidonia 1
Haikou 1
Hangzhou 1
Hanoi 1
Helsinki 1
Hyderabad 1
Jakarta 1
Jinan 1
Jönköping 1
Laurel 1
Mahé 1
Marino 1
Muizenberg 1
Oakland 1
Olgiate Olona 1
Olinda 1
Oxford 1
Paris 1
Pisa 1
Pozzuoli 1
Prague 1
Redmond 1
Rocca Priora 1
Sacramento 1
San Jose 1
Shenzhen 1
Trento 1
Trumbull 1
Venezia 1
Totale 1448
Nome #
Giant right atrium and subvalvular pulmonary stenosis: a case report of an interesting combination 93
Diabetes mellitus and ischemic heart disease. the role of ion channels 86
Genetic polymorphisms and ischemic heart disease 77
Structural and myocardial dysfunction in heart failure beyond ejection fraction 70
Myocardial ischemia and diabetes mellitus. role of oxidative stress in the connection between cardiac metabolism and coronary blood flow 68
Prevention of cardiovascular disease. screening for magnesium deficiency 68
Pharmaco-economics of levosimendan in cardiology. a european perspective 65
Heart failure with preserved, mid-range, and reduced ejection fraction. the misleading definition of the new guidelines 64
ECG evaluation in 11 949 italian teenagers. results of screening in secondary school 62
Triggers for atrial fibrillation. the role of anxiety 60
Correction to. structural and myocardial dysfunction in heart failure beyond ejection fraction (heart failure reviews, (2019), 10.1007/s10741-019-09828-8) 59
Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection. A scoping review 59
Post-sternotomy pain syndrome following cardiac surgery. case report 57
Role of ion channels in coronary microcirculation: a review of the literature. 55
Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease. 53
Cardiac involvement in consecutive unselected hospitalized COVID-19 population: in-hospital evaluation and one-year follow-up 53
Hemocompatibility of stent materials: Alterations in electrical parameters of erythrocyte membranes 47
Management of cardiac implantable electronic device follow-up in COVID-19 pandemic. Lessons learned during Italian lockdown 45
Advanced heart failure and end-stage heart failure. does a difference exist 44
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis 41
The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry 40
Coronavirus disease 2019 in Rome: was it circulating before December? 37
MULTIMODALITY IMAGING IN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANTATION DECISION MAKING IN HEART FAILURE PATIENTS: ROLE OF 123-IODINE METAIODOBENZYLGUANITIDINE IMAGING AND CARDIAC MAGNETIC RESONANCE 36
Susceptibility to ischaemic heart disease. Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors 35
Ischemic heart disease and heart failure. role of coronary ion channels 34
Selenium and Zinc Deficient Cardiomyopathy in Human Intestinal Malabsorption 33
Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak 33
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in europe. the ACVC-EAPCI EORP STEMI registry of the european society of cardiology 33
Multimodality imaging in ICD implantation decision making: 123-iodine metaiodobenzylguanidine imaging and cardiac magnetic resonance imaging 32
Ischemic heart disease pathophysiology paradigms overview. from plaque activation to microvascular dysfunction 32
The role of ranolazine for the treatment of residual angina beyond the percutaneous coronary revascularization 32
The role of cardiologists in the coronavirus disease 2019 pandemic 32
Effects of metolazone administration on congestion, diuretic response and renal function in patients with advanced heart failure 28
Myocardial ischemia in women when genetic susceptibility matters 27
Electrocardiographic features, mapping and ablation of idiopathic outflow tract ventricular arrhythmias 27
Myocardial tissue characterization in heart failure with preserved ejection fraction. from histopathology and cardiac magnetic resonance findings to therapeutic targets 27
Thromboembolic and bleeding risk in atrial fibrillation patients with chronic kidney disease: role of anticoagulation therapy 26
Ruolo dei polimorfismi genetici per i canali ionici nel determinismo della cardiopatia ischemica 24
New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation 24
Heart failure: TNM-like classification. 23
Futility in cardiology. the need for a change in perspectives 22
Potential role of eNOS genetic variants in ischemic heart disease susceptibility and clinical presentation 22
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy 16
Occult endocardial thrombosis in idiopathic left ventricular dysfunction 15
null 15
The Mutual Relationship among Cardiovascular Diseases and COVID-19: Focus on Micronutrients Imbalance 14
CT or Invasive Coronary Angiography in Stable Chest Pain. 14
Prevalence and Clinical Implications of COVID-19 Myocarditis 9
Clinical Support through Telemedicine in Heart Failure Outpatients during the COVID-19 Pandemic Period: Results of a 12-Months Follow Up 9
null 8
Impact of COVID-19 Pandemic on Cardiac Electronic Device Management and Role of Remote Monitoring 5
Clinical Support through Telemedicine in Heart Failure Outpatients during the COVID-19 Pandemic Period: Results of a 12-Months Follow Up 5
null 5
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 4
Left ventricular wall stress is associated with myocardial functional recovery in patients with severe aortic stenosis and systolic dysfunction undergoing transcatheter aortic valve replacement 3
Do the Current Guidelines for Heart Failure Diagnosis and Treatment Fit with Clinical Complexity? 3
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 3
The scar: the wind in the perfect storm-insights into the mysterious living tissue originating ventricular arrhythmias 2
Co-Management of COVID-19 and Heart Failure During the COVID-19 Pandemic: Lessons Learned 2
The scar: the wind in the perfect storm—insights into the mysterious living tissue originating ventricular arrhythmias 2
Totale 2019
Categoria #
all - tutte 3518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201814 0000 00 22 1216
2018/2019166 3188 16 215 11204447
2019/2020412 34151133 4257 7647 37221226
2020/2021301 162168 4817 625 39781918
2021/2022609 22245252 7628 2254 472912677
2022/2023488 1021322468 5964 390 0000
Totale 2019